CSF2 and neoplasm: These findings suggest that GM-CSF-driven monocyte activation is a spatially regulated process within the TME, shaping monocyte reprogramming to support immune suppression and highlighting the spatial as well as molecular complexity of the tumor-supportive myeloid compartment described in the molecular atlas73.